Meeting
2018 Gastrointestinal Cancers Symposium
Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer.
Authors
Inna Chen
Herlev University Hospital, Herlev, Denmark
Inna Chen , Christian Dehlendorff , Benny Vittrup Jensen , Per Pfeiffer , Jon K. Bjerregaard , Astrid Zedlitz Johansen , Svend Erik Nielsen , Fahimeh Andersen , Niels Henrik Hollander , Mette K. N. Yilmaz , Louise Skau Rasmussen , Julia S. Johansen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 267)
DOI
10.1200/JCO.2018.36.4_suppl.267
Abstract #
267
Poster Bd #
C20
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
The use of elevated circulating hepatocyte growth factor (HGF) level as a potential prognostic biomarker in locally advanced pancreatic cancer.
First Author: Hannah Johnson Roberts
Poster
2016 ASCO Annual Meeting
A phase II, double-blind study of galunisertib+gemcitabine (GG) vs gemcitabine+placebo (GP) in patients (pts) with unresectable pancreatic cancer (PC).
First Author: Davide Melisi
Poster
2016 Gastrointestinal Cancers Symposium
Possible role of the systemic inflammatory reaction in defining tumor responder vs. nonresponder in cancer macrobead therapy.
First Author: Barry H. Smith
Poster
2016 Gastrointestinal Cancers Symposium
A pooled analysis of long pentraxin for patients with advanced pancreatic cancer.
First Author: Mitsuhito Sasaki